Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
Therapeutic options against pathogenic human coronaviruses remain limited. In a recent clinical trial, we demonstrated the therapeutic efficacy of pegylated-IFN-λ in COVID-19 outpatients. However, the emergence of variants that have the potential to evade IFN-mediated antiviral responses raises conc...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-05-01
|
| coleção: | Virus Research |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S0168170225000371 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|